For example, would you go ahead with 20 Gy of ISRT if medical oncology has already treated a stage I-IIA patient with 2 cycles of ABVD meeting all other favorable criteria by the GHSG criteria except the ESR was not checked prior to treatment? Or would you recommend a different approach?
I'm not sure I understand Dr Huang's answer comple...